Publicaciones en las que colabora con José Ángel Ruiz Ortega (13)
2023
-
Efficacy of invasive and non-invasive methods for the treatment of Parkinson's disease: Nanodelivery and enriched environment
International Review of Neurobiology (Academic Press Inc.), pp. 103-143
2020
-
Changes in Day/Night Activity in the 6-OHDA-Induced Experimental Model of Parkinson’s Disease: Exploring Prodromal Biomarkers
Frontiers in Neuroscience, Vol. 14
2019
2016
-
Buspirone requires the intact nigrostriatal pathway to reduce the activity of the subthalamic nucleus via 5-HT1A receptors
Experimental Neurology, Vol. 277, pp. 35-45
-
Cannabinoids and Motor Control of the Basal Ganglia: Therapeutic Potential in Movement Disorders
CANNABINOIDS IN HEALTH AND DISEASE (INTECH EUROPE), pp. 59-92
-
Chronic L-DOPA administration increases the firing rate but does not reverse enhanced slow frequency oscillatory activity and synchronization in substantia nigra pars reticulata neurons from 6-hydroxydopamine-lesioned rats
Neurobiology of Disease, Vol. 89, pp. 88-100
-
Intranasal administration of chitosan-coated nanostructured lipid carriers loaded with GDNF improves behavioral and histological recovery in a partial lesion model of Parkinson's disease
Journal of Biomedical Nanotechnology, Vol. 12, Núm. 12, pp. 2220-2230
2014
-
Interaction between the 5-HT system and the basal ganglia: Functional implication and therapeutic perspective in Parkinson's disease
Frontiers in Neural Circuits, Vol. 8, Núm. MAR
-
Modulation of the subthalamic nucleus activity by serotonergic agents and fluoxetine administration
Psychopharmacology, Vol. 231, Núm. 9, pp. 1913-1924
-
Sistema serotonergikoaren eta gongoil basalen arteko elkarrekintza: inplikazio funtzionala eta terapiaren alderdia Parkinsonen gaixotasunean
Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 27, pp. 9-27
2013
-
Kannabisaren terapiarako erabilera mugimenduaren asalduretan
Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 1, pp. 129-142
2012
-
Endocannabinoid modulation of dopaminergic motor circuits
Frontiers in Pharmacology, Vol. 3 JUN
-
The role of the subthalamic nucleus in L-DOPA induced dyskinesia in 6-hydroxydopamine lesioned rats
PLoS ONE, Vol. 7, Núm. 8